Provided by Tiger Trade Technology Pte. Ltd.

Caris Life Sciences, Inc.

16.95
-1.3800-7.53%
Post-market: 16.80-0.1500-0.88%18:41 EDT
Volume:3.71M
Turnover:62.86M
Market Cap:4.78B
PE:-5.27
High:18.29
Open:18.12
Low:16.43
Close:18.33
52wk High:42.50
52wk Low:16.43
Shares:282.15M
Float Shares:91.92M
Volume Ratio:0.98
T/O Rate:4.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2173
EPS(LYR):-3.2200
ROE:-45.37%
ROA:3.84%
PB:8.28
PE(LYR):-5.26

Loading ...

Stock Track | Caris Life Sciences Soars 14.70% After-Hours on Strong Q4 Earnings Beat and Upbeat Guidance

Stock Track
·
Feb 27

Earnings Flash (CAI) Caris Life Sciences Posts Q4 EPS $0.28, vs. FactSet Est of $0.03

MT Newswires Live
·
Feb 27

Caris Life Sciences Q4 total revenue hits USD 292.9 million, up 2.3x

Reuters
·
Feb 27

Caris Life Sciences - Expects Full Year 2026 Revenue to Be in the Range of $1.0 Billion to $1.02 Billion

THOMSON REUTERS
·
Feb 27

Is Caris Life Sciences (CAI) Now Attractive After Recent Share Price Weakness

Simply Wall St.
·
Feb 26

Caris Life Sciences Inc expected to post earnings of 3 cents a share - Earnings Preview

Reuters
·
Feb 25

BRIEF-Caris Life Sciences Adds Breast Cancer Signature For Capecitabine To Ai Insights

Reuters
·
Feb 24

Caris launches AI signature predicting capecitabine response in HER2-negative breast cancer

Reuters
·
Feb 24

Caris Life Sciences Inc - Adds Breast Cancer Signature for Capecitabine to AI Insights

THOMSON REUTERS
·
Feb 24

Caris Life Sciences to Participate in TD Cowen 46th Annual Health Care Conference

Reuters
·
Feb 23

Earning Preview: Caris Life Sciences, Inc. this quarter’s revenue is expected to increase by 0%, and institutional views are mixed

Earnings Agent
·
Feb 19

Caris Life Sciences Initiated at Outperform by Baird

Dow Jones
·
Feb 17

Caris Life Sciences initiated with an Outperform at Baird

TIPRANKS
·
Feb 17

CAI Corp Completes Connected Deals, Boosts Controlling Shareholder’s Stake

TIPRANKS
·
Feb 16

CAI Corp Updates Market on HK$0.14 Net Asset Value per Share

TIPRANKS
·
Feb 13

CAI Corp Wins Strong Shareholder Backing for Equity Deals and 2026 Share Scheme

TIPRANKS
·
Feb 10

Caris Life Sciences Inc. to report fourth quarter and full year 2025 financial results

Reuters
·
Feb 09

Press Release: AudioCodes Reports Fourth Quarter and Full Year 2025 Results and Declares Semi-Annual Dividend of 20 cents per share

Dow Jones
·
Feb 03

CAI Corp Sets Out Board Line-Up and Committee Roles

TIPRANKS
·
Feb 02

CAI Corp Executive Director Chan Cheong Yee to Resign in February 2026

TIPRANKS
·
Jan 30